Absci Corp. (ABSI)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$8.82+0.23%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ABSI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 1.6 | 2.8 | 4.5 | 5.7 | 5.7 | 4.8 | 4.8 |
| Total Revenues | — | — | 4.5 | 5.7 | 5.7 | 4.8 | 4.8 |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 35.3 | 35.1 | 36.2 | 37.8 | 40.6 | 28.8 | 5.5 |
| R&D Expenses | 86.5 | 81.4 | 63.9 | 48.1 | 58.9 | 44.6 | 11.4 |
| Operating Income | (126.2) | (120.3) | (108.9) | (115.5) | (106.8) | (75.2) | (13.3) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 0.2 | 0.6 | 1.0 | 1.0 | 3.4 | 0.6 |
| Other Non-Operating Income / Expenses | 5.1 | 5.2 | 5.9 | 5.0 | 1.4 | (34.6) | (1.1) |
| EBT, Incl. Unusual Items | (121.1) | (115.1) | (103.0) | (110.5) | (105.4) | (109.9) | (14.4) |
| Income Tax Expense | 0.0 | 0.1 | 0.1 | 0.1 | (0.5) | (8.9) | 0.0 |
| Net Income | |||||||
| Net Income | (121.1) | (115.2) | (103.1) | (110.6) | (104.9) | (101.0) | (14.4) |
| Per Share | |||||||
| Basic EPS | (0.77) | (0.84) | (0.94) | (1.20) | (1.15) | (2.08) | (3.19) |
| Diluted EPS | (0.77) | (0.84) | (0.94) | (1.20) | (1.15) | (2.08) | (3.19) |
| Revenue per Share | 0.01 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 157.5 | 136.8 | 110.2 | 92.0 | 90.8 | 49.7 | 15.5 |
| Diluted Weighted Avg Shares | 157.5 | 136.8 | 110.2 | 92.0 | 90.8 | 49.7 | 15.5 |
| Supplemental | |||||||
| EBITDA | — | (108.6) | (95.5) | (101.5) | (93.7) | (68.6) | (12.2) |
| EBIT | (126.2) | (120.3) | (108.9) | (115.5) | (106.8) | (75.2) | (13.3) |
| Effective Tax Rate | 0.0% | — | — | -0.1% | 0.4% | 8.1% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.